Skip NavigationSkip to Content

Modulation of HIV-like particle assembly in vitro by inositol phosphates

  1. Author:
    Campbell, S.
    Fisher, R. J.
    Towler, E. M.
    Fox, S.
    Issaq, H. J.
    Wolfe, T.
    Phillips, L. R.
    Rein, A.
  2. Author Address

    NCI, HIV Drug Resistance Program, Frederick, MD 21702 USA. NCI, HIV Drug Resistance Program, Frederick, MD 21702 USA. NCI, Sci Applicat Int Corp, Frederick, MD 21702 USA. NCI, Dev Therapeut Program, Frederick, MD 21702 USA. Campbell S NCI, HIV Drug Resistance Program, Frederick, MD 21702 USA.
    1. Year: 2001
  1. Journal: Proceedings of the National Academy of Sciences of the United States of America
    1. 98
    2. 19
    3. Pages: 10875-10879
  2. Type of Article: Article
  1. Abstract:

    HIV-1 Gag protein assembles into 100- to 120-nm diameter particles in mammalian cells. Recombinant HIV-1 Gag protein assembles in a fully defined system in vitro into particles that are only 25-30 nm in diameter and that differ significantly in other respects from authentic particles. However, particles with the size and other properties of authentic virions were obtained in vitro by addition of inositol phosphates or phosphatidylinsitol phosphates to the assembly system. Thus, the interactions between HIV-1 Gag protein molecules are altered by binding of inositol derivatives; this binding is apparently essential for normal HIV-1 particle assembly. This requirement is not seen in a deleted Gag protein lacking residues 16-99 within the matrix domain.

    See More

External Sources

  1. No sources found.

Library Notes

  1. No notes added.
NCI at FrederickClose Button

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel